Takeda Pharmaceutical Company Limited
1-arylcarbonyl-4-oxy-piperidine compounds useful for the treatment of neurodegenerative diseases

Last updated:

Abstract:

The present invention provides a compound useful as an agent for the prophylaxis or treatment of neurodegenerative disease and the like, or a salt thereof. The present invention relates to a compound represented by the formula ##STR00001## wherein each symbol is as defined in the specification, or a salt thereof.

Status:
Grant
Type:

Utility

Filling date:

20 Jul 2020

Issue date:

16 Nov 2021